Elevated somatic mutation and evidence of genomic instability in veterans with Gulf War illness
| Autor: | Jean Johanna Latimer, Xiao-Lu Jin, Kimberly Sullivan, Omar Ibrahim, Stephen G. Grant, Nancy G. Klimas |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
0301 basic medicine Genome instability Population 030226 pharmacology & pharmacy Genomic Instability General Biochemistry Genetics and Molecular Biology 03 medical and health sciences 0302 clinical medicine Germline mutation Humans Medicine Persian Gulf Syndrome Glycophorins General Pharmacology Toxicology and Pharmaceutics Allele Mutation frequency education Veterans education.field_of_study business.industry General Medicine Haematopoiesis 030104 developmental biology medicine.anatomical_structure Case-Control Studies Mutation Immunology Mutation (genetic algorithm) Bone marrow business |
| Zdroj: | Life Sciences. 281:119746 |
| ISSN: | 0024-3205 |
| DOI: | 10.1016/j.lfs.2021.119746 |
| Popis: | Aims Gulf War illness (GWI) is thought to be associated with exposures experienced by soldiers deployed in the 1991 Gulf War. A major question is how these exposures continue to influence the health of these individuals three decades later. One potentially permanent effect of such exposures is the induction of genetic mutations. We investigated whether veterans with GWI exhibited persistently elevated levels of somatic mutation. Materials and methods We applied the blood-based glycophorin A (GPA) somatic mutation assay to a cohort of veterans diagnosed with GWI and a set of both concurrent and historic age-matched controls. This assay quantifies red blood cells with a phenotype consistent with loss of one allele at the genetic determinant for the MN blood group, the GPA gene. Key findings As a population, those affected with GWI exhibited an uninduced mutation frequency at the GPA locus that was effectively twice that observed in controls, a result that was statistically significant. This result was influenced by an increase in the incidence of individuals with aberrantly high mutation frequencies, seemingly higher than would be expected by dose extrapolation and consistent with the induction of localized genomic instability in the hematopoietic bone marrow stem cells. When these “outliers” were removed from consideration, the remaining affected population retained a significantly higher mean allele loss mutation frequency, suggesting that both dose-dependent bone marrow genotoxicity and induction of genomic instability are contributing to the elevation in mutation frequency in these affected veterans. Significance This study provides evidence that manifestation of GWI is associated with increased cumulative exposure to agents capable of inducing persistent mutations in bone marrow stem cells. Whether these mutations are involved in the clinical aspects of the condition or are simply biomarkers of overall exposure has yet to be determined. The increased incidence of genomic instability suggests that this persistent mutation can have important delayed effects on cellular integrity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect